SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-569220
Filing Date
2016-04-29
Accepted
2016-04-29 16:06:14
Documents
5
Period of Report
2016-06-16
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d101531ddef14a.htm DEF 14A 444466
2 GRAPHIC g101531g02k50gray.jpg GRAPHIC 14010
3 GRAPHIC g101531g99y44.jpg GRAPHIC 30556
4 GRAPHIC g101531pc01.jpg GRAPHIC 7536
5 GRAPHIC g101531pc02.jpg GRAPHIC 7568
  Complete submission text file 0001193125-16-569220.txt   528113
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36167 | Film No.: 161606539
SIC: 2834 Pharmaceutical Preparations